Short answer
Inmune Bio, Inc. (INMB) filed an 8-K current report with the SEC on June 2, 2026 reporting Item 8.01 (Other Events). MINDFuL Phase 2 exploratory MRI results for XPro1595 in early Alzheimer’s disease.
Inmune Bio, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 8.01 · Other Events
- MINDFuL Phase 2 exploratory MRI results for XPro1595 in early Alzheimer’s disease
- Analysis covers patients with mild cognitive impairment and mild Alzheimer’s dementia
- χ-separation MRI findings may inform XPro1595’s neuroinflammation and biomarker development
- Press release dated June 2, 2026 provides the substantive results as Exhibit 99.1
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Inmune Bio, Inc. 8-K filings
Get the next INMB 8-K as it lands
Follow INMB for push alerts, or ask the research agent what this filing means.